Quantitative Magnetic Resonance Imaging in Multiple Sclerosis:The Effect of High Dose Intravenous Methylprednisolone
JNNP 52:14-17, Kesselring,J.,et al, 1989
Motoneuron Disease:A Disorder Secondary to Solvent Exposure?
Lancet 1:73-76, 82-831989., Hawkes,C.H.,et al, 1989
Clinical Significance of Cerebrospinal Fluid Tests for Neurosyphilis
Ann Neurol 25:50-55, Davis,L.E.&Schmitt,J.W., 1989
Clinical Presentations of Vascular Malformations of the Brain Stem:Comparison of Angiographically Positive and Negative Types
JNNP 52:167-175, Abe,M.,et al, 1989
Sneddon Syndrome:CT, Arteriography, and MR Imaging
J Comput Assist Tomogr 13:119-122, Blom,R.J., 1989
Severely Threatening Events and Marked Life Difficulties Preceding Onset or Exacerbation of MS
JNNP 52:8-13, Grant,I.,et al, 1989
The Disability Status Scale for Multiple Sclerosis:Apologia Pro DSS Sau
Neurol 39:291-302, Kurtzke,J.F., 1989
Immunological Treatment for Multiple Sclerosis
Editorial, Lancet 1:699-7011989., , 1989
Treatment of Cerebellar Tremors with Carbamazepine:A Controlled Trial with Long-Term Follow-Up
Neurol 39:1113-1115, Sechi,G.P.,et al, 1989
Frequency, Etiology, and Prevention of Stroke in Patients with Systemic Lupus Erythematosus
Stroke 20:583-591, Futrell,N.&Millikan,C., 1989
Relative Diagnostic Value of Cerebrospinal Fluid Kappa Chains in MS:Comparison with Other Immunoglobulin Tests
Neurol 39:964-968, Rudnick,R.A.,et al, 1989
Patterns of Neurologic Involvement in Multiple Sclerosis
Neurol 39:1235-1238, Kurtzke,J.F., 1989
Magnetic Resonance Imaging of Spinal Cord Lesions in Multiple Sclerosis
JNNP 52:459-466, Honig,L.S.&Sheremata,W.A., 1989
A Referendum on Clinical Trial Research in Multiple Sclerosis:Opinion of Jekyll Island Workshop
Neurol 39:977-981, Noseworthy,J.H.,et al, 1989
Isolation of Herpes Simplex Virus Type 1 During First Attack of Multiple Sclerosis
Ann Neurol 26:283-285, Bergstrom,T.,et al, 1989
Diagnosis of Multiple Sclerosis, Remains Essentially Clinical Though Silent Lesions Can Now be Identified
BMJ 299:635-637, McDonald,W.I., 1989
Amantadine Treatment of Fatigue Associated with Multiple Sclerosis
Arch Neurol 46:676-680, Cohen,R.A.&Fisher,M., 1989
Relative Efficacy of Intravenous Methylprednisolone and ACTH in the Treatment of Acute Relapse in MS
Neurol 39:969-971, Thompson,A.J.,et al, 1989
Interrater Reliability of the NIH Stroke Scale
Arch Neurol 46:660-662, Goldstein,L.B.,et al, 1989
An Epidemiologic Study of Headache Among Adolescents and Young Adults
JAMA 261:2211-2216, Linet,M.S.,et al, 1989
Tuberculous Meningitis in Children:Treatment with Isoniazid and Rifampicin for Twelve Months
J Pediatr 114:875-879, Visudhiphan,P.&Chiemchanya,S., 1989
Lyme Disease
NEJM 321:586-596, Steere,A.C., 1989
Central Nervous System Manifestations of Lyme Disease
Arch Neurol 46:790-795, Pachner,A.R.,et al, 1989
Lyme Neuroborreliosis:Central Nervous System Manifestations
Neurol 39:753-759, Halperin,J.J.,et al, 1989
Short-Term Outcomes of Skull Fracture:A Population-Based Study of Survival and Neurologic Complications
Neurol 39:96-102, Wiederholt,W.C.,et al, 1989
Concurrence of Multiple Sclerosis and Inflammatory Bowel Disease
NEJM 321:762-763, Sadovnick,A.D.,et al, 1989
Significance of the Argyll Robertson Pupil in Clinical Medicine
Am J Med 86:199-202, Dacso,C.C.&Bortz,D.L., 1989
Hemorrhagic Shock and Encephalopathy:Clinical, Pathologic, and Biochemical Features
J Pediatr 114:194-203, Levin,M.,et al, 1989
Brain-Stem Auditory Evoked Potential Abnormalities with Unilateral Brain-Stem Lesions Demonstrated by MRI
Arch Neurol 46:295-299, Markand,O.N.,et al, 1989
Respiratory Complications and Their Management in Motor Neuron Disease
Brain 112:1155-1170, Howard,R.S.,et al, 1989
Inflammatory Myelinoclastic Diffuse Sclerosis (Schilder's Disease) :Neuroradiological Findings
AJNR 10:176-180, Mehler,M.F.&Rabinowich,L., 1989
Amyotrophic Lateral Sclerosis Presenting with Sleep Hypopnea Syndrome
Chest 93:1309-1312, Carre,P.C.,et al, 1988
Serum Antibodies to GM1 Ganglioside in Amytrophic Lateral Sclerosis
Neurol 38:1457-1461, Pestronk,A.,et al, 1988
Cerebral Magnetic Resonance Imaging Findings in MS, Relation to Affect, Drive and Cognition
Arch Neurol 45:1114-1116, Reischies,F.M.,et al, 1988
Serial Gadolinium Enhanced Magnetic Resonance Imaging in Multiple Sclerosis
Brain 111:927-939, Miller,D.H.,et al, 1988
Multiple Sclerosis:A Serial Study Using MRI in Relapsing Patients
Neurol 38:1511-1515, Isaac,C.,et al, 1988
Medical Decisions and Prognostications of Pediatricians for Infants with Meningomyelocele
J Pediatr 113:835-840, Siperstein,G.N.,et al, 1988
The Early Risk of Multiple Sclerosis after Optic Neuritis
JNNP 51:1569-1571, Miller,D.H.,et al, 1988
Optic Neuritis in the Elderly:Prognosis for Visual Recovery and Long-Term Follow-Up
Neurol 38:1834-1837, Jacobson,D.M.,et al, 1988
Scales for Rating Impairment in Multiple Sclerosis:A Critique
Neurol 38:1793-1798, Willoughby,E.W.&Paty,D.W., 1988
Criteria for an Increased Specificity of MRI Interpretation in Elderly with Suspected Multiple Sclerosis
Neurol 38:1822-1825, Fazekas,F.,et al, 1988
Amantadine, Fatigue, and Multiple Sclerosis
Arch Neurol 45:1104-1106, Rosenberg,G.A.&Appenzeller,O., 1988
Pain Syndromes in Multiple Sclerosis
Neurol 38:1830-1834, Moulin,D.E.,et al, 1988
Pulmonary Function and Dysfunction in Multiple Sclerosis
Arch Neurol 45:1245-1249, Smeltzer,S.C.,et al, 1988
Prediction of Delayed Cerebral Ischemia, Rebleeding, and Outcome After Aneurysmal Subarachnoid Hemorrhage
Stroke 19:1250-1256, Hijdra,A.,et al, 1988
Neuro-Behcet's Disease:CT and Clinical Correlates
Neurol 38:1714-1720, Herskovitz,S.,et al, 1988
HTLV-I-Associated Myelopathy:Oligoclonal Immunoglobulin G Bands Contain Anti-HTLV-I-p24 Antibody
Ann Neurol 24:727-731, Grimaldi,L.M.E.,et al, 1988
Primary Lateral Sclerosis, A Clinical Diagnosis Reemerges
Arch Neurol 45:1304-1307, Younger,D.S.,et al, 1988
Medullary Lesion Revealed by MRI in a Case of MS with Respiratory Arrest
Neuroradiology 30:574-576, Mochizuki,A.,et al, 1988
The Molecular Genetic Revolution, Its Impact on Clinical Neurology
Arch Neurol 45:1366-1376, Payne,C.S.&Roses,A.D., 1988